Induction of high-titer IgG antibodies against multiple leukemia-associated antigens in CML patients with clinical responses to K562/GVAX immunotherapy

por Qin, L, Smith, B D, Tsai, H-L, Yaghi, N K, Neela, P H, Moake, M, Fu, J, Kasamon, YL, Prince, G T, Goswami, M, Rosner, G L, Levitsky, H I, Hourigan, C S
Publicado 2013

Minimal information about T cell assays: the process of reaching the community of T cell immunologists in cancer and beyond

por Britten, C. M., Janetzki, S., van der Burg, S. H., Huber, C., Kalos, M., Levitsky, H. I., Maecker, H. T., Melief, C. J. M., O’Donnell-Tormey, J., Odunsi, K., Old, L. J., Pawelec, G., Roep, B. O., Romero, P., Hoos, A., Davis, M. M.
Publicado 2010

Expression of putative targets of immunotherapy in acute myeloid leukemia and healthy tissues

por Goswami, M, Hensel, N, Smith, B D, Prince, G T, Qin, L, Levitsky, H I, Strickland, S A, Jagasia, M, Savani, B N, Fraser, J W, Sadrzadeh, H, Rajkhowa, T, Ito, S, Jain, N A, Battiwalla, M, Fathi, A T, Levis, M J, Barrett, A J, Hourigan, C S
Publicado 2014